For a guy like me—a non-native speaker of English—writing daily news stories for U.S. radiologists can be a pretty frightening experience. But just as some people enjoy skydiving and others running with bulls in Spain, I get my adrenaline rush from my job.
For a guy like me-a non-native speaker of English-writing daily news stories for U.S. radiologists can be a pretty frightening experience. But just as some people enjoy skydiving and others running with bulls in Spain, I get my adrenaline rush from my job.
There is absolutely nothing that can get your juices flowing more intensely and desperately than the cold ruthlessness of a deadline. It may not sound pretty, but the beauty of it is I get rewarded as well all the way as I write. For instance, I get to be on the frontline of scientific discovery and discussion. I know that average people might never read my reports on imaging technologies and their likely clinical use. But knowing I'm writing about breakthroughs that could one day save their lives is comforting. And by virtue of being in Washington, DC, I am able to cover many of the stories begotten by the makers and shakers of radiology who are spread around the Capital Beltway.
Like any other journalist, I enjoy learning, researching, and writing about what is relevant to my readers and what is happening now. I also crave a rare feeling, perhaps not unlike what researchers and explorers savor: I was there first.
Ancient wisdom has it that enlightenment is not about reaching the finish line but enjoying the journey instead. Nonsense. Writing daily news for Diagnostic Imaging has taught me what instant gratification is all about. As much as I become enlightened by the stories I write, there is nothing sweeter than hearing two words seldom used by senior editors: nice story.
-H.A. Abella is associate editor of Diagnostic Imaging.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.